ATNM - Actinium Pharmaceuticals, Inc.
1.21
0.010 0.826%
Share volume: 32,397
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.20
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 04-26-2024 | 08-05-2024 | 11-14-2024 | 05-09-2025 | 08-08-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 90.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 90.000 K | |
| nan% | nan% | nan% | nan% | inf% | |||
| Operating expenses | 9.597 M | 12.418 M | 12.601 M | 16.638 M | 7.503 M | 5.782 M | |
| Selling general and admin | 2.962 M | 3.593 M | 2.827 M | 8.938 M | 2.624 M | 1.534 M | |
| Research and development | 6.635 M | 8.825 M | 9.774 M | 7.700 M | 4.879 M | 4.248 M | |
| Total expenses | 9.597 M | 12.418 M | 12.601 M | 16.638 M | 7.503 M | 5.782 M | |
| 29.39% | 1.47% | 32.04% | -54.90% | -22.94% | |||
| Operating income | -9.597 M | -12.418 M | -12.601 M | -16.638 M | -7.503 M | -5.692 M | |
| Ebit | -9.597 M | -12.418 M | -12.601 M | -16.638 M | -7.503 M | -5.692 M | |
| Pretax income | -8.670 M | -11.353 M | -11.568 M | -15.938 M | -6.878 M | -5.131 M | |
| 30.95% | 1.89% | 37.78% | -56.85% | -25.40% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -8.670 M | -11.353 M | -11.568 M | -15.938 M | -6.878 M | -5.131 M | |
| -30.95% | -1.89% | -37.78% | 56.85% | 25.40% |